These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6206017)

  • 1. Studies on the role of sex-hormone-binding globulin (SHBG) in benign prostatic hypertrophy in men. I. Clinical research.
    Pachman A
    Int Urol Nephrol; 1984; 16(2):141-7. PubMed ID: 6206017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma.
    Lukkarinen O
    Br J Urol; 1980 Oct; 52(5):377-80. PubMed ID: 6159037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-hormone-binding globulin in the plasma of normal men and patients with benign prostatic hypertrophy.
    Minguell JJ; Merino J; Valladares LE; Troncoso S
    Arch Androl; 1979; 3(2):167-71. PubMed ID: 92918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia.
    Ansari MA; Begum D; Islam F
    Ann Saudi Med; 2008; 28(3):174-8. PubMed ID: 18500180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the role of the sex-hormone-binding globulin (SHBG) in prostatic gland hypertrophy in men. II. In vitro research.
    Pachman A
    Int Urol Nephrol; 1984; 16(3):211-7. PubMed ID: 6207132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
    Rannikko S; Adlercreutz H
    Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders.
    Grzesiak K; Rył A; Baranowska-Bosiacka I; Rotter I; Dołęgowska B; Słojewski M; Sipak-Szmigiel O; Ratajczak W; Lubkowska A; Metryka E; Piasecka M; Laszczyńska M
    Clin Interv Aging; 2018; 13():1375-1382. PubMed ID: 30122909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma sex hormone-binding globulin binding capacity in benign prostatic hypertrophy and prostatic carcinoma: comparison with an age dependent rise in normal human males.
    Dennis M; Horst HJ; Krieg M; Voigt KD
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):207-14. PubMed ID: 64100
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
    de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH
    Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A; Kaufman JM; Giagulli VA
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 5-alpha-reductase inhibition on sex-hormone-binding globulin in elderly men.
    Jaffe A; Matzkin H; Gilad S; Stern N
    Horm Res; 1994; 41(5-6):215-7. PubMed ID: 7525442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum testosterone and sex hormone-binding globulin in adult men with intact or absent gonadal function.
    Carlström K; Eriksson A; Stege R; Rannevik G
    Int J Androl; 1990 Feb; 13(1):67-73. PubMed ID: 2312190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on sex hormone-binding globulin in the prostate].
    Jiang H; Chen Z
    Zhonghua Nan Ke Xue; 2004 Jun; 10(6):443-4, 448. PubMed ID: 15267211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys.
    Kim MR; Gupta MK; Travers SH; Rogers DG; Van Lente F; Faiman C
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):203-10. PubMed ID: 10396363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of sex hormone-binding globulin (SHBG), testosterone, and other sex steroids, on the development of type 2 diabetes in a cohort of community-dwelling middle-aged to elderly men.
    Gyawali P; Martin SA; Heilbronn LK; Vincent AD; Taylor AW; Adams RJT; O'Loughlin PD; Wittert GA
    Acta Diabetol; 2018 Aug; 55(8):861-872. PubMed ID: 29845345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sex hormone-binding globulin (SHBG) on androgen bioactivity in vitro.
    Laurent MR; Helsen C; Antonio L; Schollaert D; Joniau S; Vos MJ; Decallonne B; Hammond GL; Vanderschueren D; Claessens F
    Mol Cell Endocrinol; 2016 Dec; 437():280-291. PubMed ID: 27576188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older.
    Kim HJ; Koo HS; Kim YS; Kim MJ; Kim KM; Joo NS; Haam JH
    J Bone Miner Metab; 2017 Nov; 35(6):659-665. PubMed ID: 27873076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome.
    Haring R; Völzke H; Spielhagen C; Nauck M; Wallaschofski H
    Eur J Prev Cardiol; 2013 Dec; 20(6):1061-8. PubMed ID: 22711969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.